A Multidimensional Strategy to Improve Quality of Life of Patients With Multiple Symptoms and Palliative Care Needs

Overview

A nationwide, cross-sectional study, to determine the prevalence of symptoms of patients in the palliative phase in various care settings will be performed within a set period of two weeks in September 2018 and two weeks in November 2018. The participating settings will be selected by a total of seven coordinators, one for each consortium of palliative care in the Netherlands. To identify common combinations of symptoms and for multidimensional screening the Utrecht Symptom Diary-4 Dimensional (USD-4D) and Utrecht Symptom Diary (USD), a Dutch instrument based on the Edmonton Symptom Assessment Scale, will be used. The current protocol focuses on the cross-sectional study.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Cross-Sectional
  • Study Primary Completion Date: September 1, 2020

Detailed Description

The Utrecht Symptom Diary-4 dimensional (USD-4D), a Dutch instrument based on the Edmonton Symptom Assessment Scale, will be used for multidimensional screening and assessment of intensity and prevalence of symptoms. The questionnaire assesses twelve symptoms: pain, sleeping problems, dry mouth, dysphagia, anorexia, constipation, nausea, dyspnoea, fatigue, anxiety, depressed mood and confusion. This is measured on a numeric scale from 0 (no complaints) to 10 (worst imaginable or intolerable). The prevalence of symptoms will be described by frequencies, dichotomizing symptom scores in absent (0 on NRS) or present (1 or higher on NRS). Symptom scores of 4 or higher on NRS are considered clinically relevant. There is a possibility to add two more complaints not enlisted and to prioritise the problems which should be addressed first by the HCP. Quality of life is assessed using a (un)well-being measure and the opportunity to score the experienced value of life. Finally, five multidimensional questions will screen for mental capacity ("draagkracht"), the relationship with loved ones and thoughts concerning end of life. These multidimensional questions will be filled out together with the HCP. Therefore the HCP decides beforehand whether those questions will be asked. The USD-4D will be filled out only once by participating patients without follow-up. The patients will be asked to fill out the following characteristics: age, gender, education level, cultural background, living situation, underlying disease, comorbidities, performance score, medication groups and interventions. The estimated time to fill out both questionnaires is fifteen to twenty-five minutes.

Arms, Groups and Cohorts

  • Patients in the palliative stage
    • Adult patients in various settings will be included (General Practioners practices, home care facilities, general and academic hospitals, hospices) and with any underlying life-limiting disease.

Clinical Trial Outcome Measures

Primary Measures

  • Prevalence of multiple, simultaneously occurring symptoms
    • Time Frame: 4 weeks
    • Prevalence of multiple, simultaneously occurring symptoms (symptom clusters) in patients in the palliative phase in Dutch care settings (GP practices, home care facilities, general and academic hospitals, hospices).

Secondary Measures

  • Prevalence of each separate symptom
    • Time Frame: 4 weeks
    • For each symptom assessed (pain, sleeping problems, dry mouth, dysphagia, anorexia, constipation, nausea, dyspnoea, fatigue, anxiety, depressed mood and confusion) we will ask patients to score how they feel. In a Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10 that fits best to their experienced intensity of complaints. Zero represents ‘no complaint at all’ whereas the upper limit represents ‘the worst (pain, nausea, etc.) ever possible’.
  • Clinically relevant symptoms
    • Time Frame: 4 weeks
    • For each symptom assessed (pain, sleeping problems, dry mouth, dysphagia, anorexia, constipation, nausea, dyspnoea, fatigue, anxiety, depressed mood and confusion) we will ask patients to score how they feel. In a Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10 that fits best to their experienced intensity of complaints. Zero represents ‘no complaint at all’ whereas the upper limit represents ‘the worst (pain, nausea, etc.) ever possible’. All scores of 4 and higher are considered clinically relevant.
  • Quality of life (single question with numeric rating scale)
    • Time Frame: 4 weeks
    • Opportunity to score the experienced quality of life with the question: “how do you feel at this moment?”. In a Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10 that fits best to their wellbeing. Zero represents ‘feeling very well’ whereas the upper limit (10)represents ‘feeling very bad’.
  • Symptom burden (multidimensional questions of Utrecht Symptom Diary-4Dimensional)
    • Time Frame: 4 weeks
    • Five multidimensional theses will screen for mental capacity, the relationship with loved ones and thoughts concerning end of life. The following theses are presented: I have the chance to be myself I can bear what happens to me I can let go of my loved ones I am living a balanced life Thoughts at the end of life gives me peace of mind In a Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10 that fits best to their experienced feeling. Zero represents ‘totally agree’ whereas the upper limit represents ‘totally disagree’. These values will be descriptive, a higher or lower value is not necessarily a better or worse outcome.
  • Symptoms per care setting
    • Time Frame: 4 weeks
    • Number of participants with assessed complaints (pain, sleeping problems, dry mouth, dysphagia, anorexia, constipation, nausea, dyspnoea, fatigue, anxiety, depressed mood and confusion) per care setting (general practitioners practices, home care facilities, general and academic hospitals, hospices)
  • Symptoms per underlying disease
    • Time Frame: 4 weeks
    • Number of participants with assessed complaints (pain, sleeping problems, dry mouth, dysphagia, anorexia, constipation, nausea, dyspnoea, fatigue, anxiety, depressed mood and confusion) per underlying disease (most probably incurable cancer, chronic obstructive pulmonary disease, heart failure and end-stage renal disease).

Participating in This Clinical Trial

Patient selection will be performed by health care providers in the participating settings. Inclusion Criterium: • Patients of whom the health care professional answers "no" to the question "Would I be surprised if this patient died in the next 12 months ?". Exclusion Criterium: •Patients unable or unwilling to self-assess their symptoms

Gender Eligibility: All

Minimum Age: 16 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Medical Center Groningen
  • Provider of Information About this Clinical Study
    • Principal Investigator: A.K.L. Reyners, Prinicipal investigator – University Medical Center Groningen
  • Overall Official(s)
    • An KL Reyners, MD, PhD, Principal Investigator, University Medical Center Groningen

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.